Labeling stem cells with superparamagnetic iron oxide nanoparticles: Analysis of the labeling efficacy by microscopy and magnetic resonance imaging

Methods in Molecular Biology

Volumn 906, Issue , 2012, Pages 239-252

  Jasmin, ^a   Torres, Ana Luiza MacHado ^a   Jelicks, Linda ^b   De Carvalho, Antonio Carlos Campos ^a,b   Spray, David C ^b   Mendez Otero, Rosalia ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cell labeling; Ferumoxides; Magnetic resonance imaging; Stem cells; Superparamagnetic iron oxide nanoparticles

Indexed keywords

DEXTRAN; DIAGNOSTIC AGENT; MAGNETITE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CELL TRACKING; CHEMISTRY; CYTOLOGY; FLUORESCENCE MICROSCOPY; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; STAINING; STEM CELL;

CELL TRACKING; DEXTRANS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MESENCHYMAL STEM CELLS; MICROSCOPY, FLUORESCENCE; STAINING AND LABELING; STEM CELLS;

EID: 84864862402     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-953-2_18     Document Type: Article

References (35)

1. Guzman R et al (2007) Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A 104: 10211-10216 (Pubitemid 47175288)
2. Sykova E, Jendelova P (2007) Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ 14:1336-1342 (Pubitemid 46965263)
3. Hoehn M et al (2002) Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99:16267-16272 (Pubitemid 35462784)
4. Dodd SJ et al (1999) Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 76:103-109 (Pubitemid 29202442)
5. Jendelova P et al (2004) Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 76:232-243 (Pubitemid 38451211)
6. Shapiro EM et al (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A 101:10901-10906 (Pubitemid 38989558)
7. Farrell E et al (2008) Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun 369: 1076-1081
8. Modo M et al (2002) Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 17:803-811 (Pubitemid 35317014)
9. Lewin M et al (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18:410-414 (Pubitemid 30217528)
10. Dodd CH et al (2001) Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptidederived superparamagnetic nanoparticles. J Immunol Methods 256:89-105 (Pubitemid 32769920)
11. Ahrens ET et al (2003) Receptor-mediated endocytosis of iron-oxide particles provides ef fi cient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 49: 1006-1013 (Pubitemid 36627278)
12. Frank JA et al (2003) Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228:480-487 (Pubitemid 36910091)
13. Weissleder R et al (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 152:167-173 (Pubitemid 19024086)
14. Molday RS, MacKenzie D (1982) Immunospeci fi c ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 52:353-367 (Pubitemid 12044733)
15. Kim HS et al (2010) The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells. NMR Biomed 23:514-522
16. Modo M et al (2004) Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 21:311-317 (Pubitemid 38115022)
17. Brekke C et al (2007) The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry. NMR Biomed 20:77-89 (Pubitemid 46470930)
18. Greisberg JK et al (2001) Gadolinium inhibits thymidine incorporation and induces apoptosis in chondrocytes. J Orthop Res 19:797
19. Babic M et al (2008) Poly(L-lysine)-modi fi ed iron oxide nanoparticles for stem cell labeling. Bioconjug Chem 19:740-750 (Pubitemid 351431406)
20. Arbab AS et al (2003) Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 76:1123-1130 (Pubitemid 37280845)
21. Jasmin et al (2011) Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging. J Nanobiotechnology 9:4
22. Arbab AS et al (2004) Ef fi cient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104: 1217-1223 (Pubitemid 39038047)
23. Janic B et al (2009) Optimization and validation of FePro cell labeling method. PLoS One 4:e5873
24. van Buul GM et al (2009) Ferumoxidesprotamine sulfate is more effective than ferucarbotran for cell labeling: implications for clinically applicable cell tracking using MRI. Contrast Media Mol Imaging 4:230-236
25. Qiu B, Yang X (2008) Molecular MRI of hematopoietic stem-progenitor cells: in vivo monitoring of gene therapy and atherosclerosis. Nat Clin Pract Cardiovasc Med 5:396-404 (Pubitemid 351935573)
26. Walczak P et al (2005) Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 54:769-774 (Pubitemid 41457046)
27. Tai JH et al (2006) Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla. Diabetes 55:2931-2938
28. Qiu B et al (2010) Magnetosonoporation: instant magnetic labeling of stem cells. Magn Reson Med 63:1437-1441
29. Arbab AS et al (2005) Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 18:553-559 (Pubitemid 43013896)
30. Kostura L et al (2004) Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 17:513-517 (Pubitemid 39549429)
31. Bull BS et al (1975) Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 69:685-689
32. Gervin AS (1975) Complications of heparin therapy. Surg Gynecol Obstet 140:789-796
33. Bourrinet P et al (2006) Preclinical safety and pharmacokinetic pro fi le of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 41:313-324 (Pubitemid 44406193)
34. Liu W, Frank JA (2009) Detection and quanti fi cation of magnetically labeled cells by cellular MRI. Eur J Radiol 70:258-264
35. Smirnov P et al (2006) Single-cell detection by gradient echo 9.4 T MRI: a parametric study. Contrast Media Mol Imaging 1:165-174